Outcomes After 4-Week Course of Sofosbuvir/Velpatasvir Therapy in Hepatitis C Seronegative Recipients of Kidneys From Hepatitis C Viremic Deceased Donors. [PDF]
Kummangal BA +10 more
europepmc +1 more source
Real-world effectiveness of pangenotypic direct-acting antivirals in chronic hepatitis C: A retrospective cohort study. [PDF]
Çirkin Doruk B, Uğuz M.
europepmc +1 more source
Unravelling HCV diversity and resistance in Viet Nam: a cross-sectional analysis. [PDF]
Le Ngoc C +24 more
europepmc +1 more source
Increasing competition in pharmaceutical tenders: Patents, treatment guidelines, and centralised procurement of Hepatitis C drugs in Brazil. [PDF]
Mercadante E.
europepmc +1 more source
Hepatitis C in the Direct-Acting Antiviral Era: Immunopathogenesis, Dendritic Cells and Modern Clinical Management. [PDF]
Kurmangaliyeva K +7 more
europepmc +1 more source
Evaluation of serum MicroRNAs and HCV Core antigen as predictive and diagnostic biomarkers for chronic hepatitis C management in Iraqi patients: comparison with PCR-based detection. [PDF]
Al-Mawla BSO, Khalil MA, Majeed YH.
europepmc +1 more source
Direct-Acting Antiviral Therapy and Hepatocellular Carcinoma in Captive Chimpanzees With Long-Standing Chronic Hepatitis C Virus Infection. [PDF]
Hirata S +4 more
europepmc +1 more source
Treatment of hepatitis C in children and adolescents: our experience to date, current status, and prospects. [PDF]
Pokorska-Śpiewak M +4 more
europepmc +1 more source
Safety and Drug-Drug Interaction Burden of Direct-Acting Antiviral Therapy for Hepatitis C: A Single-Center Community Hospital Analysis. [PDF]
Okabe S +5 more
europepmc +1 more source
Immediate Donor-Derived Hepatitis C Transmission Following Kidney Transplantation: A Two-Case Observation. [PDF]
Chen IR, Su WP, Lai PC.
europepmc +1 more source

